| LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson’s Disease? DM O’Hara, G Pawar, SK Kalia, LV Kalia Frontiers in Neuroscience, 2020 | 74 | 2020 |
| Minimally invasive nasal depot (MIND) technique for direct BDNF AntagoNAT delivery to the brain S Padmakumar, G Jones, G Pawar, O Khorkova, J Hsiao, J Kim, MM Amiji, ... Journal of Controlled Release, 2021 | 48 | 2021 |
| Disrupting the α-synuclein-ESCRT interaction with a peptide inhibitor mitigates neurodegeneration in preclinical models of Parkinson’s disease S Nim, DM O’Hara, C Corbi-Verge, A Perez-Riba, K Fujisawa, M Kapadia, ... Nature Communications 14 (1), 2150, 2023 | 35 | 2023 |
| MicroRNA-34a encapsulated in hyaluronic acid nanoparticles induces epigenetic changes with altered mitochondrial bioenergetics and apoptosis in non-small-cell lung cancer cells M Trivedi, A Singh, M Talekar, G Pawar, P Shah, M Amiji Scientific reports 7 (1), 1-17, 2017 | 34 | 2017 |
| Direct CNS delivery of proteins using thermosensitive liposome-in-gel carrier by heterotopic mucosal engrafting GN Pawar, NN Parayath, AL Nocera, BS Bleier, MM Amiji PloS one 13 (12), e0208122, 2018 | 25 | 2018 |
| Small molecule inhibitors of α-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans KS Chen, K Menezes, JB Rodgers, DM O’Hara, N Tran, K Fujisawa, ... Molecular Neurodegeneration 16 (1), 1-25, 2021 | 21 | 2021 |
| CNS Delivery and Anti-Inflammatory Effects of Intranasally Administered Cyclosporine-A in Cationic Nanoformulations S Yadav, G Pawar, P Kulkarni, C Ferris, M Amiji Journal of Pharmacology and Experimental Therapeutics 370 (3), 843-854, 2019 | 18 | 2019 |
| Endonasal CNS Delivery System for Blood-Brain Barrier Impermeant Therapeutic Oligonucleotides Using Heterotopic Mucosal Engrafting G Pawar, NN Parayath, AA Sharma, C Coito, O Khorkova, J Hsiao, ... Frontiers in Pharmacology 12, 854, 2021 | 12 | 2021 |
| Neurodegenerative disease NN Parayath, G Pawar, C Avachat, MM Miyake, B Bleier, MM Amiji Nanomedicine for inflammatory diseases. CRC Press, Boca Raton/London, 289-318, 2017 | 4 | 2017 |
| Reduction of alpha synuclein oligomers in preclinical models of Parkinson’s disease by electrical stimulation in vitro and deep brain stimulation in vivo EJ Lee, DH Aguirre-Padilla, A Fomenko, G Pawar, M Kapadia, J George, ... Brain Stimulation, 2024 | 2 | 2024 |
| Trans-nasal Mucosal Delivery of BDNF AntagoNAT Oligonucleotides Using Heterotopic Mucosal Engrafting for Parkinson's Disease GN Pawar Northeastern University, 2019 | 2 | 2019 |
